Frequently Bought Together
Designed for STR genotyping, this antibody-mediated hot-start enzyme combines Hieff UNICON™ Taq Antibody with Hieff™ Taq DNA Polymerase. The antibody keeps polymerase activity blocked even after 30 minutes at 50℃ and is fully inactivated within 30 seconds at the initial denaturation temperature, releasing active polymerase. This helps minimize amplification caused by nonspecific primer annealing. The thermostable recombinant polymerase has high template affinity, making it well suited to low-copy-number targets. Formulation additives further improve blocking efficiency and room-temperature stability.
Feature
Excellent stability: Contains additives that enhance blocking efficiency, providing good room-temperature stability.
High amplification efficiency: Thermostable recombinant DNA polymerase with high template affinity, ideal for low-copy template amplification.
Broad applicability: Suitable for conventional PCR, hot-start PCR, qPCR, and high-throughput sequencing.
Components
|
Cat. No. |
Name |
14226ES72 (500 U) |
14226ES80 (5000 U) |
14226ES92 (25000 U) |
14226ES93 (50000 U) |
14226ES94 (100000 U) |
|
14226 |
HotStart Taq DNA Polymerase (5 U/μL) |
100 μL |
1 mL |
5 mL |
10 mL |
20 mL |
Application Examples
1. Amplification Performance
A positive control from a forensic testing kit was amplified using YEASEN Taq polymerase 14226 and comparable commercial enzymes. Under the conditions tested, 14226 produced higher overall peak heights, indicating stronger detection performance.

Figure 1. Amplification performance comparison.
2. Specificity
No-template controls (NTCs) were tested using YEASEN Taq polymerase 14226 and two comparable commercial enzymes. The 14226 reactions showed no nonspecific peaks, while both comparator enzymes produced nonspecific peaks to varying degrees, demonstrating higher specificity under the conditions tested.

Figure 2. Specificity comparison in no-template controls.
Storage
FAQ
Citations
Applications
당신은 또한 좋아할 수 있습니다
문의
자주 묻는 질문
이 제품은 연구 목적으로만 사용되며 인간이나 동물의 치료 또는 진단용으로 의도되지 않았습니다. 제품과 콘텐츠는
특정 애플리케이션에는 추가적인 제3자 지적 재산권이 필요할 수 있습니다.
예슨은 윤리적 과학에 헌신하며, 우리의 연구가 안전과 윤리적 기준을 보장하는 동시에 중요한 문제를 해결해야 한다고 믿습니다.

